BD2Decide uses data coming from population-based cancer registries contributing to the RARECARENet high resolution study.

RARECARENet is a project funded by the Consumers, Health, Agriculture and Food Executive Agency (Chafea) of the European Commission (formerly known as the Executive Agency for Health and Consumers, EAHC).

Moreover, BD2Decide team members Lisa Licitra, Gemma Gatta, Annalisa Trama are also actively working on RARECARENet, particularly on WORK PACKAGE  6 - Information on clinical management of rare cancers, which aims at developing information on diagnosis and treatment for a selected number of rare cancers and will develop new information on very rare cancers.



Share This Post: